Current morbimortality and one-year survival after pneumonectomy for infectious diseases

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Citação
CLINICS, v.78, article ID 100169, 4p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: Identify the one-year survival rate and major complications in patients submitted to pneumonectomy for infectious disease.Methods: Retrospective data from all cases of infectious disease pneumonectomy over the past 10 years were collected from two reference centers. The authors analyzed: patient demographics, etiology, laterality, bronchial stump treatment, presence of previous pulmonary resection, postoperative complications in the first 30 days, the treatment used in pleural complications, and one-year survival rate.Results: 56 procedures were performed. The average age was 44 years, with female predominance (55%). 29 cases were operated on the left side (51%) and the most frequent etiology was post-tuberculosis (51.8%). The overall incidence of complications was 28.6% and the most common was empyema (19.2%). Among empyema cases, 36.3% required pleurostomy, 27.3% required pleuroscopy and 36.3% underwent thoracoplasty for treatment. Bronchial stump fistula was observed in 10.7% of cases. From all cases, 16.1% were completion pneumonectomies and 62.5% of these had some complication, a significantly higher incidence than patients without previous surgery (p = 0.0187). 30-day in-hospital mortality was (7.1%) with 52 cases (92.9%) and 1-year survival. The causes of death were massive postoperative bleeding (1 case) and sepsis (3 cases).Conclusions: Pneumonectomy for benign disease is a high-risk procedure performed for a variety of indications. While morbidity is often significant, once the perioperative risk has passed, the one-year survival rate can be very satisfying in selected patients with benign disease.
Palavras-chave
Pneumonectomy, Infectious disease, Tuberculosis, survival, mortality
Referências
  1. Ashour M, 1997, EUR J CARDIO-THORAC, V12, P209, DOI 10.1016/S1010-7940(97)00155-3
  2. Bai LQ, 2012, EUR J CARDIO-THORAC, V41, P335, DOI 10.1016/j.ejcts.2011.05.028
  3. CONLAN AA, 1995, J THORAC CARDIOV SUR, V110, P1118, DOI 10.1016/S0022-5223(05)80181-3
  4. Erdogan A, 2005, ANN THORAC SURG, V79, P299, DOI 10.1016/j.athoracsur.2004.05.016
  5. Fox GJ, 2016, CLIN INFECT DIS, V62, P887, DOI 10.1093/cid/ciw002
  6. GINSBERG RJ, 1983, J THORAC CARDIOV SUR, V86, P654
  7. Halezeroglu S, 1997, ANN THORAC SURG, V64, P1635, DOI 10.1016/S0003-4975(97)00999-5
  8. HARMON H, 1976, ANN SURG, V183, P719, DOI 10.1097/00000658-197606000-00016
  9. Hu XF, 2013, ANN THORAC SURG, V95, P1899, DOI 10.1016/j.athoracsur.2013.03.051
  10. Klapper J, 2014, J AM COLL SURGEONS, V219, P518, DOI 10.1016/j.jamcollsurg.2014.01.062
  11. Mariani AW, 2021, EUR J CARDIO-THORAC, V59, P1272, DOI 10.1093/ejcts/ezaa454
  12. Massard G, 1996, ANN THORAC SURG, V62, P1033, DOI 10.1016/0003-4975(96)00596-6
  13. Miller DL, 2002, ANN THORAC SURG, V74, P876, DOI 10.1016/S0003-4975(02)03855-9
  14. Mohamed E, 2021, EGYPT CARDIOTHORAC S, V3, P70
  15. Olcmen Aysun, 2006, Asian Cardiovasc Thorac Ann, V14, P363
  16. Owen RM, 2013, EUR J CARDIO-THORAC, V43, P312, DOI 10.1093/ejcts/ezs284
  17. PATEL RL, 1992, ANN THORAC SURG, V54, P84, DOI 10.1016/0003-4975(92)91145-Y
  18. Pricopi C, 2015, INTERACT CARDIOV TH, V20, P316, DOI 10.1093/icvts/ivu417
  19. Puri V, 2013, ANN THORAC SURG, V95, P1885, DOI 10.1016/j.athoracsur.2013.04.014
  20. REED CE, 1995, ANN THORAC SURG, V59, P408, DOI 10.1016/0003-4975(94)00867-7
  21. Shapiro M, 2010, ANN THORAC SURG, V90, P927, DOI 10.1016/j.athoracsur.2010.05.041
  22. Shiraishi Y, 2000, ANN THORAC SURG, V70, P1202, DOI 10.1016/S0003-4975(00)01612-X
  23. Speicher PJ, 2014, J AM COLL SURGEONS, V218, P439, DOI 10.1016/j.jamcollsurg.2013.12.005
  24. Visca D, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10082734